drug presumably acts potent agonist cannabinoid never previously reported scientific patent literature first identified laboratories japan july ingredient synthetic cannabis smoking like closely related first reported around year earlier thus appears another novel compound invented designer drug suppliers specifically recreational use structurally hybrid two known cannabinoid compounds previously used active ingredients synthetic cannabis blends banned many countries acts full agonist binding affinity nm nm cannabinoid united states receptor agonists class schedule controlled banned new zealand temporary class drug december reports addiction psychosis associated use products containing active ingredient however protested users claim found medical benefits treatment conditions phantom limb pain since medicinal marijuana available new zealand synthetic cannabis products used legal anlage ii controlled drug germany october controlled substance forensic standard available commonly used mass